{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T06:28:31Z","timestamp":1777616911989,"version":"3.51.4"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2006,5,5]],"date-time":"2006-05-05T00:00:00Z","timestamp":1146787200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Eye"],"published-print":{"date-parts":[[2007,7]]},"DOI":"10.1038\/sj.eye.6702367","type":"journal-article","created":{"date-parts":[[2006,5,6]],"date-time":"2006-05-06T11:49:09Z","timestamp":1146916149000},"page":"968-975","source":"Crossref","is-referenced-by-count":51,"title":["Tacrolimus ointment vs steroid ointment for eyelid dermatitis in patients with atopic keratoconjunctivitis"],"prefix":"10.1038","volume":"21","author":[{"given":"E","family":"Nivenius","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"I","family":"van der Ploeg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K","family":"Jung","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E","family":"Chryssanthou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M","family":"van Hage","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P G","family":"Montan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2006,5,5]]},"reference":[{"key":"BF6702367_CR1","first-page":"265","volume":"50","author":"MJ Hogan","year":"1952","unstructured":"Hogan MJ . Atopic keratoconjunctivitis. Trans Am Acad Ophthalmol Otolaryngol 1952; 50: 265\u2013281.","journal-title":"Trans Am Acad Ophthalmol Otolaryngol"},{"key":"BF6702367_CR2","doi-asserted-by":"publisher","first-page":"482","DOI":"10.1001\/archopht.1963.00960050484010","volume":"70","author":"MF Armaly","year":"1963","unstructured":"Armaly MF . Effect of corticosteroids on intraocular pressure and fluid dynamics. I. The effect of dexamethasone on the normal eye. Arch Ophthalmol 1963; 70: 482\u2013491.","journal-title":"Arch Ophthalmol"},{"key":"BF6702367_CR3","doi-asserted-by":"publisher","first-page":"492","DOI":"10.1001\/archopht.1963.00960050494011","volume":"70","author":"MF Armaly","year":"1963","unstructured":"Armaly MF . Effect of corticosteroids on intraocular pressure and fluid dynamics. II. The effect of dexamethasone on the glaucomatous eye. Arch Ophthalmol 1963; 70: 492\u2013499.","journal-title":"Arch Ophthalmol"},{"key":"BF6702367_CR4","first-page":"198","volume":"26","author":"B Becker","year":"1965","unstructured":"Becker B . Intraocular pressure response to topical corticosteroids. Invest Ophthalmol 1965; 26: 198\u2013205.","journal-title":"Invest Ophthalmol"},{"key":"BF6702367_CR5","doi-asserted-by":"publisher","first-page":"439","DOI":"10.2165\/00002512-199915060-00004","volume":"15","author":"RC Tripathi","year":"1999","unstructured":"Tripathi RC, Parapuram SK, Tripathi BJ, Zhong Y, Chalam KV . Corticosteroids and glaucoma risk. Drugs Aging 1999; 15: 439\u2013450.","journal-title":"Drugs Aging"},{"key":"BF6702367_CR6","doi-asserted-by":"publisher","first-page":"664","DOI":"10.1038\/eye.1993.152","volume":"7","author":"RK Aggarwal","year":"1993","unstructured":"Aggarwal RK, Potamitis T, Chong NH, Guarro M, Shah P, Kheterpal S . Extensive visual loss with topical facial steroids. Eye 1993; 7: 664\u2013666.","journal-title":"Eye"},{"key":"BF6702367_CR7","doi-asserted-by":"publisher","first-page":"828","DOI":"10.1097\/01.ico.0000127484.46584.f6","volume":"23","author":"GD Kymionis","year":"2004","unstructured":"Kymionis GD, Tsilimbaris MK, Iliaki OE, Christodoulakis E, Siganos CS, Pallikaris IG . Treatment of atopic eyelid disease using topical tacrolimus following corticosteroid discontinuation in a patient with open-angle glaucoma. Cornea 2004; 23: 828\u2013830.","journal-title":"Cornea"},{"key":"BF6702367_CR8","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1111\/j.1442-9071.2004.00787.x","volume":"32","author":"HM Garrott","year":"2004","unstructured":"Garrott HM, Walland MJ . Glaucoma from topical corticosteroids to the eyelids. Clin Experiment Ophthalmol 2004; 32: 224\u2013226.","journal-title":"Clin Experiment Ophthalmol"},{"key":"BF6702367_CR9","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1034\/j.1600-0846.2001.70203.x","volume":"7","author":"L Kolbe","year":"2001","unstructured":"Kolbe L, Klingman AM, Schreiner V, Stoudemayer T . Corticosteroid-induced atrophy and barrier impairment measured by non-invasive methods in human skin. Skin Res Technol 2001; 7: 73\u201377.","journal-title":"Skin Res Technol"},{"key":"BF6702367_CR10","doi-asserted-by":"publisher","first-page":"999","DOI":"10.1001\/archderm.136.8.999","volume":"136","author":"AB Fleischer Jr","year":"2000","unstructured":"Fleischer Jr AB, Ling M, Eichenfield L, Satoi Y, Jaracz E, Rico MJ et al. Safety and efficacy of 1 year of tacrolimus ointment monotherapy in adults with atopic dermatitis. The European Tacrolimus Ointment Study Group. Arch Dermatol 2000; 136: 999\u20131006.","journal-title":"Arch Dermatol"},{"key":"BF6702367_CR11","doi-asserted-by":"publisher","first-page":"S28","DOI":"10.1067\/mjd.2001.109810","volume":"44","author":"JM Hanifin","year":"2001","unstructured":"Hanifin JM, Ling MR, Langley R, Breneman D, Rafal E . Tacrolimus ointment for the treatment of atopic dermatitis in adult patients: Part I. efficacy. J Am Acad Dermatol 2001; 44: S28\u2013S38.","journal-title":"J Am Acad Dermatol"},{"key":"BF6702367_CR12","doi-asserted-by":"publisher","first-page":"S39","DOI":"10.1067\/mjd.2001.109817","volume":"44","author":"NA Soter","year":"2001","unstructured":"Soter NA, Fleischer Jr AB, Webster GF, Monroe E, Lawrence I . Tacrolimus ointment for the treatment of atopic dermatitis in adult patients: Part II. Safety. J Am Acad Dermatol 2001; 44: S39\u2013S46.","journal-title":"J Am Acad Dermatol"},{"key":"BF6702367_CR13","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1016\/S0002-9394(02)01982-7","volume":"135","author":"SM Rikkers","year":"2003","unstructured":"Rikkers SM, Holland GN, Drayton GE, Michel FK, Torres MF, Takahashi S . Topical tacrolimus treatment of atopic eyelid disease. Am J Ophthalmol 2003; 135: 297\u2013302.","journal-title":"Am J Ophthalmol"},{"key":"BF6702367_CR14","first-page":"267","volume":"73","author":"AK Freeman","year":"2004","unstructured":"Freeman AK, Serle J, VanVeldhuisen P, Lind L, Clarke J, Singer G et al. Tacrolimus ointment in the treatment of eyelid dermatitis. Cutis 2004; 73: 267\u2013271.","journal-title":"Cutis"},{"key":"BF6702367_CR15","doi-asserted-by":"publisher","first-page":"468","DOI":"10.1097\/01.ico.0000116521.57227.4c","volume":"23","author":"T Kawakita","year":"2004","unstructured":"Kawakita T, Takano Y, Asano-Kato N, Tanaka M, Dogru M, Goto E et al. Quantitative evaluation of eyelid elasticity using the cutometer SEM575 and its clinical application in assessing the efficacy of tacrolimus ointment treatment in eyelid atopic dermatitis. Cornea 2004; 23: 468\u2013471.","journal-title":"Cornea"},{"key":"BF6702367_CR16","doi-asserted-by":"publisher","first-page":"733","DOI":"10.1055\/s-2001-18665","volume":"218","author":"K Mayer","year":"2001","unstructured":"Mayer K, Reinhard T, Reis A, Bohringer D, Sundmacher R . FK 506 ointment 0.1%\u2014a new therapeutic option for atopic blepharitis. Clinical trial with 14 patients. Klin Monatsbl Augenheilkd 2001; 218: 733\u2013736.","journal-title":"Klin Monatsbl Augenheilkd"},{"key":"BF6702367_CR17","doi-asserted-by":"publisher","first-page":"816","DOI":"10.1056\/NEJM199709183371203","volume":"18","author":"T Ruzicka","year":"1997","unstructured":"Ruzicka T, Bieber T, Schopf E, Rubins A, Dobozy A, Bos JD et al. A short-term trial of tacrolimus ointment for atopic dermatitis. European Tacrolimus Multicenter Atopic Dermatitis Study Group. N Engl J Med 1997; 18: 816\u2013821.","journal-title":"N Engl J Med"},{"key":"BF6702367_CR18","doi-asserted-by":"publisher","first-page":"725","DOI":"10.1111\/j.1365-2222.2004.1950.x","volume":"34","author":"E Nivenius","year":"2004","unstructured":"Nivenius E, Montan PG, Chryssanthou E, Jung K, van Hage-Hamsten M, van der Ploeg I . No apparent association between periocular and ocular microcolonization and the degree of inflammation in patients with atopic keratoconjunctivitis. Clin Exp Allergy 2004; 34: 725\u2013730.","journal-title":"Clin Exp Allergy"},{"key":"BF6702367_CR19","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1067\/mai.2002.121832","volume":"109","author":"S Reitamo","year":"2002","unstructured":"Reitamo S, Rustin M, Ruzicka T, Cambazard F, Kalimo K, Friedmann PS et al, European Tacrolimus Ointment Study Group. Efficacy and safety of tacrolimus ointment compared with that of hydrocortisone butyrate ointment in adult patients with atopic dermatitis. J Allergy Clin Immunol 2002; 109: 547\u2013555.","journal-title":"J Allergy Clin Immunol"},{"key":"BF6702367_CR20","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1055\/s-2002-26727","volume":"219","author":"T Reinhard","year":"2002","unstructured":"Reinhard T, Reis A, Mayweg S, Oberhuber H, Mathis G, Sundmacher R . Topical Fk506 in inflammatory corneal and conjunctival diseases. A pilot study. Klin Monatsbl Augenheilkd 2002; 219: 125\u2013131.","journal-title":"Klin Monatsbl Augenheilkd"},{"key":"BF6702367_CR21","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1067\/mai.2001.112131","volume":"107","author":"A Remitz","year":"2001","unstructured":"Remitz A, Kyllonen H, Granlund H, Reitamo S . Tacrolimus ointment reduces staphylococcal colonization of atopic dermatitis lesions. J Allergy Clin Immunol 2001; 107: 196\u2013197.","journal-title":"J Allergy Clin Immunol"},{"key":"BF6702367_CR22","doi-asserted-by":"publisher","first-page":"562","DOI":"10.1067\/mjd.2002.124603","volume":"47","author":"AB Fleischer Jr","year":"2002","unstructured":"Fleischer Jr AB, Ling M, Eichenfield L, Satoi Y, Jaracz E, Rico MJ et al, Tacrolimus Ointment Study Group. Tacrolimus ointment for the treatment of atopic dermatitis is not associated with an increase in cutaneous infections. J Am Acad Dermatol 2002; 47: 562\u2013570.","journal-title":"J Am Acad Dermatol"},{"key":"BF6702367_CR23","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1016\/j.jjo.2003.08.003","volume":"47","author":"J Shoji","year":"2003","unstructured":"Shoji J, Kato H, Kitazawa M, Inada N, Sawa M . Evaluation of staphylococcal enterotoxin-specific IgE antibody in tears in allergic keratoconjunctival disorders. Jpn J Ophthalmol 2003; 47: 609\u2013611.","journal-title":"Jpn J Ophthalmol"},{"key":"BF6702367_CR24","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1111\/j.1365-2133.1986.tb04064.x","volume":"114","author":"I Rystedt","year":"1986","unstructured":"Rystedt I, Strannegard IL, Strannegard O . Recurrent viral infections in patients with past or present atopic dermatitis. Br J Dermatol 1986; 114: 575\u2013582.","journal-title":"Br J Dermatol"},{"key":"BF6702367_CR25","first-page":"21","volume":"19","author":"JA Garrity","year":"1984","unstructured":"Garrity JA, Liesegang TJ . complications of atopic dermatitis. Can J Ophthalmol 1984; 19: 21\u201324.","journal-title":"Can J Ophthalmol"},{"key":"BF6702367_CR26","doi-asserted-by":"publisher","first-page":"965","DOI":"10.1016\/S0190-9622(03)02139-X","volume":"49","author":"J Lubbe","year":"2003","unstructured":"Lubbe J, Saurat JH . Cutaneous infections with herpes simplex virus and tacrolimus ointment. J Am Acad Dermatol 2003; 49: 965\u2013966.","journal-title":"J Am Acad Dermatol"},{"key":"BF6702367_CR27","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1097\/01.ico.0000151507.49565.6e","volume":"24","author":"MA Joseph","year":"2005","unstructured":"Joseph MA, Kaufman HE, Insler M . Topical tacrolimus ointment for treatment of refractory anterior segment inflammatory disorders. Cornea 2005; 24: 417\u2013420.","journal-title":"Cornea"},{"key":"BF6702367_CR28","doi-asserted-by":"publisher","first-page":"788","DOI":"10.1016\/0002-9394(77)90497-4","volume":"84","author":"J McCulley","year":"1978","unstructured":"McCulley J, Sciallis GF . Meibomian keratoconjunctivitis. Am J Ophthlmol 1978; 84: 788\u2013792.","journal-title":"Am J Ophthlmol"},{"key":"BF6702367_CR29","doi-asserted-by":"publisher","first-page":"1358","DOI":"10.1016\/S0161-6420(93)31475-2","volume":"100","author":"W Culbertson","year":"1993","unstructured":"Culbertson W, Huang AJ, Mandelbaum SH, Pflugfelder SC, Boozalis GT, Miller D . Effective treatment of phlyctenular keratoconjunctivitis with oral tetracycline. Ophthalmology 1993; 100: 1358\u20131366.","journal-title":"Ophthalmology"},{"key":"BF6702367_CR30","doi-asserted-by":"publisher","first-page":"1141","DOI":"10.1002\/(SICI)1097-0142(19970915)80:6<1141::AID-CNCR18>3.0.CO;2-8","volume":"15","author":"S Jonas","year":"1997","unstructured":"Jonas S, Rayes N, Neumann U, Neuhaus R, Bechstein WO, Guckelberger O et al. De novo malignancies after liver transplantation using tacrolimus-based protocols or cyclosporine-based quadruple immunosuppression with an interleukin-2 receptor antibody or antithymocyte globulin. Cancer 1997; 15: 1141\u20131150.","journal-title":"Cancer"},{"key":"BF6702367_CR31","doi-asserted-by":"publisher","first-page":"960","DOI":"10.1111\/j.1365-2133.2003.05735.x","volume":"149","author":"Y Niwa","year":"2003","unstructured":"Niwa Y, Terashima T, Sumi H . Topical application of the immunosuppressant tacrolimus accelerates carcinogenesis in mouse skin. Br J Dermatol 2003; 149: 960\u2013967.","journal-title":"Br J Dermatol"},{"issue":"1","key":"BF6702367_CR32","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1186\/1471-2407-6-7","volume":"6","author":"JC Becker","year":"2006","unstructured":"Becker JC, Hoube R, Vetter CS, Broecker EB . The carcinogenic potential of tacrolimus ointment beyond immune suppression: a hypothesis creating case report. BMC Cancer 2006; 6(1): 7.","journal-title":"BMC Cancer"},{"key":"BF6702367_CR33","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1080\/09546630510041088","volume":"16","author":"M Naylor","year":"2005","unstructured":"Naylor M, Elmets C, Jaracz E, Rico JM . Non-melanoma skin cancer in patients with atopic dermatitis treated with topical tacrolimus. J Dermatol Treat 2005; 16: 149\u2013153.","journal-title":"J Dermatol Treat"},{"key":"BF6702367_CR34","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1016\/j.jaci.2005.08.060","volume":"117","author":"DW Aaronson","year":"2006","unstructured":"Aaronson DW . The \u2018black box\u2019 warning and allergy drugs. J Allergy Clin Immunol 2006; 117: 40\u201344.","journal-title":"J Allergy Clin Immunol"},{"key":"BF6702367_CR35","doi-asserted-by":"publisher","first-page":"701","DOI":"10.1111\/j.1365-2133.2005.06899.x","volume":"153","author":"AD Ormerod","year":"2005","unstructured":"Ormerod AD . Topical tacrolimus and pimecrolimus and the risk of cancer: how much cause for concern? Br J Dermatol 2005; 153: 701\u2013705.","journal-title":"Br J Dermatol"}],"container-title":["Eye"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/6702367.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/6702367","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/6702367.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,18]],"date-time":"2023-05-18T12:25:41Z","timestamp":1684412741000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/6702367"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,5,5]]},"references-count":35,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2007,7]]}},"alternative-id":["BF6702367"],"URL":"https:\/\/doi.org\/10.1038\/sj.eye.6702367","relation":{},"ISSN":["0950-222X","1476-5454"],"issn-type":[{"value":"0950-222X","type":"print"},{"value":"1476-5454","type":"electronic"}],"subject":[],"published":{"date-parts":[[2006,5,5]]}}}